Roundtable Discussion; The Future of Mineral Sands. Watch the video here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksBenchmark Holdings Regulatory News (BMK)

Share Price Information for Benchmark Holdings (BMK)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 43.20
Bid: 44.10
Ask: 45.90
Change: -0.50 (-1.10%)
Spread: 1.80 (4.082%)
Open: 43.00
High: 43.20
Low: 43.00
Prev. Close: 45.50
BMK Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Land-based Broodstock Facility Reaches Milestone

30 Oct 2017 07:00

RNS Number : 9021U
Benchmark Holdings PLC
30 October 2017
 

Benchmark Holdings plc("Benchmark" or the "Company")

 

Construction of land-based salmon broodstock facility reaches significant milestone

 

Benchmark today announces that its new land-based salmon broodstock facility in Norway is now ready to house its first batch of broodstock. The 10,000 square-meter facility will receive delivery of the first stock in November from Salten, the joint venture partner of Benchmark's subsidiary SalmoBreed, who have been growing SalmoBreed's genetic material. Salmon eggs from this stock will be produced early Autumn 2018 and first test batch sales are expected two months later.

 

The new facility will deliver eggs throughout the year for the entire production cycle and will be the first of its kind to do so in Norway. Smolt (young salmon) from SalmoBreed's breeding station in Lønningdal will also be delivered in November. This new site, which is based on Benchmark's Icelandic model, is fully-biosecure and has the capacity to produce over 150 million ova per year.

 

The build of the facility is on schedule and is expected to reach full capacity by Autumn 2019.

 

Malcolm Pye, Benchmark CEO, commented:

"SalmoBreed Salten will be the world's most advanced facility. This additional capacity will allow us to take up our production to meet the increasing demand for disease free, year-round salmon ova and support the strong growth of the Norwegian salmon industry.

 

"Norway is a leading player in salmon and there is a continuous drive towards improvements in production efficiency traits, disease resistance and product quality . Benchmark are well-placed to address this through our robust breeding programmes that are proven to tackle some of the industry's biggest challenges."

 

 

-ENDS-

 

Benchmark Holdings plc

Tel: 020 7920 3150

Malcolm Pye, CEO

Rachel Aninakwah, Communications

Numis

Tel: 020 7260 1000

Michael Meade / Freddie Barnfield (NOMAD)

James Black (Corporate Broking)

Tavistock

Tel: 020 7920 3150

Sophie Praill / Simon Hudson

 

Notes to Editors:

Benchmark challenges the status quo in aquaculture, agriculture and animal healthcare.

 

Since 2000, Benchmark has consistently worked to build a platform to serve its customers, helping farmers to take control of their biological environment through the combination of genetics, nutrition, health and knowledge services. Through its in-depth knowledge of animal biology, Benchmark is able to tackle the key issues in the aquaculture, livestock and companion animal sectors.

 

The Company has proven distribution capabilities in high growth markets and operates internationally with R&D facilities, commercial farms, diagnostic laboratories, manufacturing sites, production facilities and commercial offices across 27 countries in five continents. As at 30 September 2017, Benchmark employed 952 people. 

 

For further information on Benchmark please visit www.benchmarkplc.com 

 

 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
NRABIBDGXDDBGRC
Date   Source Headline
22nd Mar 20169:07 amRNSBlocklisting Interim Review
10th Mar 201610:13 amRNSResult of AGM
5th Feb 20162:51 pmRNSDirector Dealings
2nd Feb 20167:00 amRNSFinal Results
7th Jan 201611:02 amRNSHolding(s) in Company
5th Jan 201612:08 pmRNSHolding(s) in Company
4th Jan 20163:04 pmRNSHolding(s) in Company
4th Jan 20163:00 pmRNSHolding(s) in Company
4th Jan 201611:18 amRNSHolding(s) in Company
4th Jan 201610:47 amRNSHolding(s) in Company
4th Jan 201610:43 amRNSHolding(s) in Company
4th Jan 201610:40 amRNSHolding(s) in Company
4th Jan 20169:26 amRNSHolding(s) in Company
4th Jan 20169:19 amRNSHolding(s) in Company
31st Dec 20157:00 amRNSFurther admission of shares
29th Dec 201511:43 amRNSResult of General Meeting
14th Dec 201511:00 amRNSSchedule 1 - Benchmark Holdings plc
14th Dec 20157:30 amRNSRestoration - Benchmark Holdings plc
14th Dec 20157:00 amRNSPlacing and Acquisition
9th Nov 20157:00 amRNSCanine Vaccine Licensing Deal Secured
6th Nov 201511:28 amRNSResponse to Lumpfish VHS
8th Oct 20152:43 pmRNSFurther re. potential acquisition
8th Oct 201512:15 pmRNSPotential acquisition and suspension of shares
8th Oct 201512:15 pmRNSSuspension - Benchmark Holdings Plc
30th Sep 20157:00 amRNSSalmoBreed breakthrough
30th Sep 20157:00 amRNSTotal Voting Rights
16th Sep 20157:00 amRNSBlock Admission Application
27th Jul 20157:00 amRNSAcquisition
13th Jul 20153:40 pmRNSHolding(s) in Company
23rd Jun 20157:00 amRNSHalf Yearly Report
6th May 20155:46 pmRNSHolding(s) in Company
30th Apr 201512:44 pmRNSHolding(s) in Company
29th Apr 20157:00 amRNSTrading Statement
23rd Apr 201512:34 pmRNSHolding(s) in Company
17th Mar 201512:25 pmRNSHolding(s) in Company
10th Mar 20151:13 pmRNSDirector Share Options
5th Mar 201510:43 amRNSResult of AGM
26th Feb 20152:39 pmRNSHolding(s) in Company
16th Feb 20151:51 pmRNSHolding(s) in Company
3rd Feb 201512:59 pmRNSHolding(s) in Company
2nd Feb 20157:00 amRNSAcquisition
27th Jan 20157:01 amRNSFinal Results
8th Jan 20152:21 pmRNSHolding(s) in Company
6th Jan 201510:53 amRNSHolding(s) in Company
19th Dec 20144:32 pmRNSHolding(s) in Company
19th Dec 20144:26 pmRNSHolding(s) in Company
19th Dec 20144:24 pmRNSHolding(s) in Company
19th Dec 20144:20 pmRNSHolding(s) in Company
19th Dec 20144:14 pmRNSHolding(s) in Company
18th Dec 20144:38 pmRNSResult of General Meeting

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.